CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 4 Planned sale EVP R&D, Chief Medical Officer sold 9,000 shares at $41.67 ($375,044)
- 144 Insider Sale of Securities
- 4 Open-market sale VP, Finance (Interim PAO) sold 16,217 shares at $42.36 ($687,007)
- 4 Shares withheld for taxes Director gave up 1,475 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,475 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,475 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,475 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,475 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,475 shares (to pay taxes)
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Shares withheld for taxes Director gave up 1,475 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 3,207 shares (to pay taxes)
- 8-K Event Executive or director change · Shareholder vote results
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- DEFA14A Proxy Proxy Materials
- 8-K Event Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale EVP, CLO, Alkermes, Inc. sold 2,034 shares at $33.20 ($67,529)
Page 3 of 97 · 1,927 filings